The relevance of CBP enabling efficient inactivation of SFKs by CSK has also been proven to be crucial in preventing tumorigenesis and controlling GFR signalling in cancer (Jiang et al., 2006; Gargalionis et al., 2014; Li et al., 2016; Nozaki et al., 2019). The gene discussed is CSK; the disease is cancer.